n Cardiovascular Journal of South Africa - Evidence for use of low molecular weight heparin (Clexane) in STEMI : drug trends in cardiology

Volume 14, Issue 5
  • ISSN : 1680-0745



Extracted from text ... 282 The use of enoxaparin (Clexane) as a better choice than unfractionated heparin in non-ST-segment acute coronary syndromes has been well established by expert consensus.1 Recent results of HART-II, ASSENT-3, AMISK, Baird et al., and ENTIRE-TIMI 23 are building a picture of growing evidence for using enoxaparin as a better choice, also in ST-segment elevation acute myocardial infarction (STEMI). A recent meta-analysis collected this data and evaluated benefit and risk.2 The analysis included a total of 6 069 patients, 1 108 of them treated with streptokinase (SK), 400 with t-PA, and 4 561 with tenecteplase. The rates of acute myocardial infarction ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error